Domača stranBICO • STO
add
BICO Group AB
Prejšnji trg. dan.
36,26 kr
Dnevni razpon
35,80 kr - 36,80 kr
Letni razpon
27,16 kr - 56,55 kr
Tržna kapitalizacija
2,49 mrd. SEK
Povprečni obseg
121,26 tis.
Razm. P/E
-
Dividendna donosnost
-
Primarna borza
STO
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (SEK) | mar. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 388,60 mio. | −17,35 % |
Stroški poslovanja | 289,00 mio. | −24,80 % |
Čisti dohodek | −234,00 mio. | −729,79 % |
Čista dobičkovnost prihodkov | −60,22 | −903,67 % |
Earnings per share | — | — |
EBITDA | −13,80 mio. | 36,99 % |
Efektivna davčna stopnja | −1,42 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (SEK) | mar. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 684,30 mio. | −14,00 % |
Skupna sredstva | 4,74 mrd. | −19,97 % |
Skupne obveznosti | 2,08 mrd. | −27,47 % |
Celoten lastniški kapital | 2,66 mrd. | — |
Shares outstanding | 70,57 mio. | — |
Razmerje P/B | 0,97 | — |
Donosnost sredstev | −3,87 % | — |
Donosnost kapitala | −4,47 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (SEK) | mar. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | −234,00 mio. | −729,79 % |
Denar iz dejavnosti | 76,60 mio. | 542,77 % |
Denar iz naložb | −5,70 mio. | 86,90 % |
Denar iz financiranja | −299,90 mio. | −1.728,66 % |
Neto sprememba denarnih sredstev | −237,20 mio. | −263,25 % |
Prost denarni tok | −232,51 mio. | −981,15 % |
Vizitka
Bico Group is a Swedish bioconvergence company that designs and supplies technologies and services to enhance biology research. It focuses on commercializing technologies for life science research as well as bioprinting.
Bico Group began by producing bio-inks and bioprinters for culturing different cell types to enable applications like patient-derived implants. Bico Group was the first company to provide a standardized bio-ink product for sale over the internet.
The company has ongoing collaborations with organizations including AstraZeneca, MedImmune, MIT and Takara Bio, and its bioprinters are used for research at Harvard University, Merck, Novartis, the U.S. Army, Toyota, Johnson & Johnson and more. Wikipedia
Datum ustanovitve
27. jan. 2016
Spletno mesto
Zaposleni
695
